HCA Health Inc vs Uranium Energy Corp — how do they compare? HCA Health Inc trades at $443.69 (market cap $95.08B), while Uranium Energy Corp trades at $9.23 (market cap $4.69B). The key difference: HCA Health Inc is far larger — about 20.3× Uranium Energy Corp's market cap, and HCA Health Inc pays a 0.71% dividend while Uranium Energy Corp pays none. Which is the better fit depends on your goals — on Pluang, investors hold HCA Health Inc for 76 Days and Uranium Energy Corp for 37 Days on average.
| HCA | UEC | |
|---|---|---|
Market Cap | $95.08B | $4.69B |
Volume | 998,787 | 8,957,476 |
Sector | Health | Energy |
52-Week High | $545.13 | $20.14 |
52-Week Low | $361.32 | $9.04 |
Typical Hold Time | 76 Days | 37 Days |
Enterprise Value | $145.62B | $4.20B |
Dividend Yield | 0.71% | — |
Signals from Pluang's Aura AI — not financial advice
HCA Healthcare (HCA) trades at $445.01, up 2.96% today, with a bullish technical signal and strong earnings beats in recent quarters. Revenue grew to $75.6B in 2025, with net income of $6.78B, and the stock trades at a P/E of 14.73. Analyst consensus is a Buy with a $461.12 price target, though ongoing legal investigations pose a headwind.
The outlook remains positive given solid demand and cost controls, but risks include payer-mix pressure and high debt levels. Upside potential exists if earnings growth continues, but investors should monitor legal developments and interest rate impacts on the leveraged balance sheet.
Uranium Energy (UEC) trades at $9.47, down 6.33% today, amid bearish technical signals despite strong analyst support. The company reported fiscal 2026 revenue of $37M with a net loss of $137M, reflecting operational expansion but negative profitability. Recent news highlights UEC's transition to a multi-mine producer with improved production scale and a $93.13 realized uranium price, though earnings quality concerns persist due to inventory-driven revenue.
UEC presents a high-risk, high-reward opportunity with Wall Street optimism (87.5% buy ratings, $16.06 consensus target) contrasting weak fundamentals. Key risks include sustained losses, unproven production sustainability, and uranium price volatility. The stock's upside depends on successful execution of U.S. uranium production ramp-up amid growing nuclear demand.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.
Read more on HCA →Uranium Energy Corp is a leading American uranium mining and exploration company, currently holding the largest resource base and licensed production capacity in the United States. Utilizing low-cost, environmentally friendly In-Situ Recovery (ISR) mining, UEC is a central player in the domestic nuclear fuel supply chain, transitioning from a resource holder to an active producer and refiner to meet the accelerating demand for carbon-free energy.
Read more on UEC →